Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
The Korean Journal of Laboratory Medicine ; : 201-201, 2010.
Artículo en Inglés | WPRIM | ID: wpr-151618

RESUMEN

No abstract available.

2.
The Korean Journal of Laboratory Medicine ; : 28-33, 2010.
Artículo en Coreano | WPRIM | ID: wpr-121790

RESUMEN

BACKGROUND: Antimicrobial susceptibility of Legionella spp. has rarely been studied in Korea. Therefore, we aimed to determine the susceptibility of Legionella spp. to various antibiotics. METHODS: We assessed the antimicrobial susceptibility of 66 environmental and clinical Legionella isolates collected between January 2001 and December 2008 from Korea and Japan. The minimum inhibitory concentrations (MICs) of 6 antibiotics, namely, azithromycin, ciprofloxacin, clarithromycin, clindamycin, gatifloxacin, and gemifloxacin were determined by the broth microdilution method using buffered starch yeast extract broth. RESULTS: The MIC ranges of the 6 antibiotics used against the Legionella isolates were as follows: 0.004-0.062 microgram/mL (azithromycin), 0.002-0.5 microgram/mL (ciprofloxacin), 0.004-0.5 microgram/mL (clarithromycin), 0.12-4 microgram/mL (clindamycin), 0.002-0.12 microgram/mL (gatifloxacin), and 0.008-1 microgram/mL (gemifloxacin). CONCLUSIONS: Legionella spp. isolates from Korea and Japan were most susceptible to gatifloxacin. Azithromycin, clarithromycin, ciprofloxacin, and gemifloxacin were also effective for treating legionellosis.


Asunto(s)
Humanos , Antibacterianos/farmacología , Azitromicina/farmacología , Ciprofloxacina/farmacología , Claritromicina/farmacología , Clindamicina/farmacología , Farmacorresistencia Bacteriana , Fluoroquinolonas/farmacología , Legionella/efectos de los fármacos , Legionelosis/diagnóstico , Pruebas de Sensibilidad Microbiana , Naftiridinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA